Nanjing Pharmaceutical Co Ltd Class A 600713
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.72
- Day Range
- CNY 4.69–4.75
- 52-Week Range
- CNY 3.85–6.45
- Bid/Ask
- CNY 4.73 / CNY 4.74
- Market Cap
- CNY 6.21 Bil
- Volume/Avg
- 9.6 Mil / 9.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 10.42
- Price/Sales
- 0.11
- Dividend Yield (Trailing)
- 2.97%
- Dividend Yield (Forward)
- 2.97%
- Total Yield
- 2.95%
Company Profile
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Value
- Total Number of Employees
- 4,903
- Website
- http://www.guangyuyuan.com
Comparables
Valuation
Metric
|
600713
|
002424
|
600285
|
---|---|---|---|
Price/Earnings (Normalized) | 10.42 | 52.28 | 26.59 |
Price/Book Value | 0.97 | 2.23 | 4.87 |
Price/Sales | 0.11 | 2.04 | 4.07 |
Price/Cash Flow | 4.47 | 26.03 | 15.20 |
Price/Earnings
600713
002424
600285
Financial Strength
Metric
|
600713
|
002424
|
600285
|
---|---|---|---|
Quick Ratio | — | 1.01 | 1.02 |
Current Ratio | — | 1.46 | 1.33 |
Interest Coverage | — | 2.75 | — |
Quick Ratio
600713
002424
600285
Profitability
Metric
|
600713
|
002424
|
600285
|
---|---|---|---|
Return on Assets (Normalized) | 1.81% | 2.26% | 13.37% |
Return on Equity (Normalized) | 9.27% | 3.94% | 22.70% |
Return on Invested Capital (Normalized) | 5.84% | 4.46% | 20.78% |
Return on Assets
600713
002424
600285
Drug Manufacturers - General Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Hmrdkhmw | Mdc | $697.4 Bil | |
JNJ
| Johnson & Johnson | Jbhsgns | Sjlx | $353.8 Bil | |
MRK
| Merck & Co Inc | Fxvcxdkm | Bpppk | $332.3 Bil | |
ABBV
| AbbVie Inc | Vhhbwnhh | Scd | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Yslfzqxfq | Wslx | $232.3 Bil | |
NVS
| Novartis AG ADR | Sjbgprjlt | Dmd | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Wgvcmctjvx | Bmgv | $195.3 Bil | |
AMGN
| Amgen Inc | Fqmdydwzs | Wzy | $144.5 Bil | |
PFE
| Pfizer Inc | Ynjhxjdc | Nky | $143.8 Bil | |
SNY
| Sanofi SA ADR | Hhcsbrk | Sqy | $122.2 Bil |